camonagrel has been researched along with thromboxane b2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De La Cruz, JP; García Campos, J; Moreno, A; Ruiz-Ruiz, MI; Sánchez de la Cuesta, F | 1 |
Arrebola, MM; De La Cruz, JP; Escalante, R; Guerrero, A; Sánchez de la Cuesta, F; Villalobos, MA | 1 |
2 other study(ies) available for camonagrel and thromboxane b2
Article | Year |
---|---|
Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.
Topics: Animals; Blood Cell Count; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Fibrinolysis; Imidazoles; Indans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Retinal Neovascularization; Streptozocin; Thromboxane B2; Thromboxane-A Synthase | 1998 |
Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction.
Topics: Adolescent; Adult; Animals; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Humans; Imidazoles; Indans; Male; Middle Aged; Platelet Aggregation; Prostaglandins; Prostaglandins E; Rabbits; Thrombosis; Thromboxane B2; Thromboxane-A Synthase; Tunica Intima | 2003 |